Engine Biosciences secures US$27m for precision oncology and biomarkers
Existing investors, ClavystBio and Invus participated in the & nbsp, roundFunds will aid in advancing biomarkers, target discoveries through collaboration & nbsp,Engine Biosciences, a company leveraging machine learning and high – throughput biology to discover and develop precision oncology medicines has announced the completion of a US$ 27 million( RM125.5 million…Continue Reading